Sun's U.S. Unit Issues Another Recall, Of 41,127 Antidepressant Bottles
This article was originally published in PharmAsia News
Sun Pharmaceutical Industries has been hit with another U.S. recall, this one of 41,127 bottles of venlafaxine, an antidepressant produced by its U.S. subsidiary, Caraco Pharmaceutical Laboratories.
You may also be interested in...
CBER Director Marks will no longer have to recuse himself from COVID-19 product reviews, a move seen as resoundingly positive by former senior FDA leaders. CDER Director Woodcock will now be free to focus solely on COVID-19 and bring her unique depth of agency experience to the Trump Administration's effort to speed development of vaccines, therapeutics and diagnostics for coronavirus.
Three-fourths of sunscreens marketed in the US offer “inferior” protection or contain “worrisome” chemicals, according to the Environmental Working Group’s 2020 Sunscreen Guide. The guide shows overwhelming preference for mineral over chemical sunscreens, while also suggesting that Americans would be better off if UVA-protective chemical filters in Europe were allowed stateside.